Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

BioHealx® Anal Fistula Device Post Market Surveillance Study

NCT: NCT07021742 · RECRUITING

NCT IDNCT07021742
StatusRECRUITING
Start Date2025-06-14
Completion2026-12

Brief Summary

This post market surveillance study is a single arm multicenter study to demonstrate the long-term durability and effectiveness of the BioHealx Anal Fistula Device for fistula-in-ano closure (internal and external fistula openings).

Frequently Asked Questions

What is BioHealx® Anal Fistula Device Post Market Surveillance Study?

BioHealx® Anal Fistula Device Post Market Surveillance Study is a clinical trial registered under NCT07021742. Current status: RECRUITING.

What is the status of NCT07021742?

The current status of NCT07021742 (BioHealx® Anal Fistula Device Post Market Surveillance Study) is: RECRUITING.

When did BioHealx® Anal Fistula Device Post Market Surveillance Study start?

BioHealx® Anal Fistula Device Post Market Surveillance Study started on 2025-06-14.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑